UK Deep-Tech Startup StandardX Secures £10 Million Seed Funding to Address Global Rare Isotope Shortage
StandardX, a UK deep‑tech startup founded in 2025, secured £10 million in seed capital led by Vsquared Ventures to build a novel accelerator platform that can produce a range of rare isotopes for cancer diagnostics, targeted therapies and fusion energy, aiming to create a resilient European supply chain for these critical materials.